ISOFLURANE USP 99.9 %
ISOFLURANE : 99.9 % · DIN 02231929 · FRESENIUS KABI CANADA LTD
Health Canada status: MARKETED
What is ISOFLURANE USP?
ISOFLURANE USP 99.9 % contains ISOFLURANE : 99.9 %. It is listed in the Health Canada Drug Product Database under DIN 02231929, held by FRESENIUS KABI CANADA LTD, supplied as LIQUID for INHALATION administration. Health Canada currently lists it as marketed, status dated 25-Sep-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ISOFLURANE USP used for?
Isoflurane is indicated for induction and maintenance of general anesthesia. It can be used in various age groups, including geriatrics and pediatrics, with dosage adjusted based on age and individual patient needs.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02231929 |
|---|---|
| Brand name | ISOFLURANE USP |
| Generic / active ingredient | ISOFLURANE : 99.9 % |
| Manufacturer | FRESENIUS KABI CANADA LTD |
| Strength | 99.9 % |
| Dosage form | LIQUID |
| Route of administration | INHALATION |
| Schedule | Prescription |
| ATC code | N01AB06 ISOFLURANE |
| AHFS class | 28:04.16 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 25-Sep-2015 |
| Original market date | 1997-11-14 00:00:00 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code N01AB06 ISOFLURANE. 2 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FORANE | 100 % | LIQUID | BAXTER CORPORATION | MARKETED | DIN 02188856 |
| FORANE LIQ INH | 100 % | LIQUID | OHMEDA PHARMACEUTICAL PRODUCTS, DIVISION OF BOC CANADA LIMITED | CANCELLED POST MARKET | DIN 02056666 |
| ISOFLURANE USP | 100 % | LIQUID | TECHNILAB PHARMA INC. | CANCELLED POST MARKET | DIN 02237684 |
| ISOFLURANE USP | 99.9 % | LIQUID | ABBVIE CORPORATION | CANCELLED POST MARKET | DIN 02032384 |
| ISOFLURANE USP | 99.9 % | LIQUID | HALOCARBON LABORATORIES, A DIVISION OF HALOCARBON PRODUCTS CORP | CANCELLED POST MARKET | DIN 02241315 |
Who else supplies ISOFLURANE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ISOFLURANE appears in 16 registered pack listings across 5 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.